Curtana Pharmaceuticals is a privately-held, preclinical-stage biopharmaceutical company developing first-in-class, small molecule therapeutics that are highly specific for cancer stem cells in the central nervous system (CNS) for the treatment of glioblastoma (GBM) and other brain cancers.

Pharmaceutical

Biotechnology

Curtana Pharmaceuticals

Gregory Stein

Fabio Tucci

David M. Weiner

Daniel Pertschuk

Mark Sorenson

Lawrence J. Trost

Michelle Rose

Scientific Advisors

Leadership Team

Product Development and Regulatory Team

Teams at Curtana Pharmaceuticals

Scientific Advisors

Leadership Team

Product Development and Regulatory Team